{
  "id": 4163466,
  "title": "Landmark approval for pancreatic cancer; Reactions to Lilly’s Phase 1 secrecy; and more",
  "url": "https://urgent.news/2026/08/29/landmark-approval-for-pancreatic-cancer-reactions-to-lillys-phase-1",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-29T10:00:51.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/landmark-approval-for-pancreatic-cancer-reactions-to-lillys-phase-1-secrecy-and-more/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Welcome back to Endpoints Weekly! The big news this week was the FDA’s approval of Revolution Medicines’ pancreatic cancer treatment Rasonque. The drug stunned researchers and spurred excitement in April, when it nearly doubled patients’ ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}